Prebo Barango, Co-chair of the UN Joint Action Group for the Cervical Cancer Elimination Initiative at the World Health Organization (WHO), and Nicholas Banatvala, Head of the Secretariat for the UN Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, discuss the challenges and progress in the efforts to eliminate cervical cancer.
The European Commission has created five new policy goals - four of them centred around climate change, with the push to become largely "climate resilient" by 2030.
Christine Hancock, Co-founder of C3 Collaborating for Health, and C3 Associate and nutritionist Nathalie Vauterin, explore how poverty, dietary behaviours, and food systems impact malnutrition.
Prof Dangou from the WHO Regional Office for Africa, Congo, speaks about the different kinds of skin cancer:non-melanoma skin cancers and malignant melanoma.
CEO of Dxcover Limited, Mark Hegarty, offers an insight into their cutting-edge technology that can help save lives by detecting early signs of cancer.
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.
Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.
A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.
With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
